JESSICA RILEY: Open Payments
NPI 1992579759 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,152 in 176 payments from 31 companies in 2025. Trend: 2023 $196 · 2024 $1,865 · 2025 $5,152
Food & beverage: $3,840Travel & lodging: $1,312
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 18 | $2,127 |
| ABBVIE INC. | 52 | $842 |
| Eisai Inc. | 10 | $253 |
| UCB, Inc. | 17 | $191 |
| Biogen, Inc. | 11 | $171 |
| ARGENX US, INC. | 7 | $170 |
| Genentech USA, Inc. | 5 | $146 |
| Lilly USA, LLC | 6 | $134 |
| Otsuka America Pharmaceutical, Inc. | 1 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $95 |
Products named: INFINITY, BOTOX, PROCLAIM, QULIPTA, Leqembi, VYALEV, TYSABRI, VYVGART HYTRULO.
Industry payments across AZ — which companies pay providers there.
